TABLE 1.
Clinical details of NNAB/ART+ patient cohort
| NNAB identifier | Study no. | No. of yrs of known HIV infectiona | PMIc (h) | CSF VL (no. of copies/mm3) | Blood VL (no. of copies/mm3) | Last living blood VL (no. of copies/mm3) | Cancer diagnosis |
|---|---|---|---|---|---|---|---|
| 4149 | C01 | 20 | 20.5 | <40 | <40 | <40 | Non-Hodgkin's lymphoma |
| 5095 | C02 | 3.6 | 8 | <400 | <40 | <400 | Plasmacytoma/myeloma, meningoencephalitis |
| 4154 | C03 | 13 | 13 | <40 | <40 | <40 | Anal carcinoma, non-Hodgkin's lymphoma |
| 4143 | C04 | 4.6 | 4 | <40 | <400 | <40 | Kaposi's sarcoma, non-Hodgkin's lymphoma, kidney tumor |
| 1010 | C05 | 12.1 | 3.5 | <400 | <40 | <400 | Basal cell carcinoma, prostate cancer, anal carcinoma, hepatic metastasis |
| NAb | KS1 | 7.7 | NA | NA | NA | NA | Kaposi's sarcoma |
| NA | KS3 | 8.5 | NA | NA | NA | NA | Kaposi's sarcoma |
a
Based on date of diagnoses in clinical records.
b
NA, not applicable.
c
Postmortem interval.